Core Laboratories Inc. (CLB) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
As of 2026-11-01, Core Laboratories Inc. (NYSE: CLB) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $10.40 (-0.86% 1D, market cap $477.2M). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 17/20, and SEC Balance-Sheet Forensics 16/20. Across 211 tracked Energy issuers, CLB ranks #52 in composite RQD confidence.
Within the Energy sector (Oilfield Services/Equipment), CLB carries a Roarable C+ (68/100 RQD), trailing P/E of 16.1x, gross margin of 20.7%, and ROIC of 12.6%. By comparison, NGS (Natural Gas Services Group Inc.) holds a D- grade (38/100 RQD, P/E 21.3x, ROIC 10.7%, cap $424.1M) and RNGR (Ranger Energy Services Inc. (Class A)) posts a D+ grade (57/100 RQD, P/E 29.4x, ROIC 4.2%, cap $361.3M). Among the 5-stock peer group, CLB leads on earnings multiple (16.1x) while CLB leads on capital efficiency (12.6% ROIC).
Per CLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001958086), Core Laboratories Inc. generated $526.5M in revenue (+0.5% YoY), $29.7M in net income, and $25.8M in free cash flow against $584.0M in total assets and $110.3M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
FRED Regime × Technicals: 11% of 52W Range • RSI-14 at 54.9 (NEUTRAL RANGE)
SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)
Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)
Even with a 68/100 (C+) score, CLB faces multiple-compression risk if 16.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Broader market pullbacks can still drag down strong stocks in the short run.
Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 18.2% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($10.99) or 200D SMA ($13.87) invalidates the momentum regime and cuts Target Base ($10.87) toward Bear Floor ($8.48).
Core Laboratories Inc. (CLB) slipped -0.86% to $10.40, trading at 11% of its 52-week range ($9.13 – $20.36). Solid 21% profit margin (13% return on capital), mixed timing at 16x P/E—hold if owned, no rush to chase.
Core Laboratories faced continued headwinds in Q3 2026, with revenue declining year over year and operating margins pressured by persistent geopolitical conflicts in the Middle East and Eastern Europe. Management attribu
Core Laboratories just reported Q3 2026 results and the instant verdict from the market has been almost a shrug. The stock is trading near US$10.40, only fractionally above the prior close, even after the numbers hit. Th
Core Laboratories (NYSE:CLB) reported higher third-quarter revenue, operating income and earnings per share from the prior quarter, while geopolitical disruptions in the Middle East and Russia-Ukraine continued to constr
Oilfield services company Core Laboratories (NYSE:CLB) met Wall Street’s revenue expectations in Q3 2026, but sales fell by 1.8% year on year to $132.1 million. Its non-GAAP profit of $0.16 per share was in line with ana
Revenue grew 6% sequentially to $132.1 million amid Middle East disruptions.
Core Laboratories Inc. (CLB) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDTCompany ParticipantsLawrence Bruno - Chairman of the Board, CEO, President...
Core Laboratories (CLB) delivered earnings and revenue surprises of -5.88% and +0.84%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
HOUSTON (AP) — HOUSTON (AP) — Core Laboratories Inc. (CLB) on Wednesday reported profit of $5.
Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported third quarter 2026 revenue of $132,100,000. Core's operating income was $12,100,000, with earnings per diluted share ("EPS") of $0.12,
Oilfield services company Core Laboratories (NYSE:CLB) met Wall Street’s revenue expectations in Q3 2026, but revenue fell by 1.8% year on year to $132.1 million. Its non-GAAP profit of $0.16 per share was in line with a
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +0.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CLB today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CLB. Explore sector supply chains on /butterfly.
Across 211 tracked Energy securities in the Roarable RQD universe, Core Laboratories Inc. (CLB) ranks #52 by composite RQD confidence (68/100, grade C+) and #154 by equity capitalization ($477.2M). Within this direct 5-issuer industry benchmark cohort, CLB leads on earnings valuation at 16.1x trailing P/E, while CLB leads on capital efficiency and profitability with 12.6% ROIC and 20.7% gross margin. CLB currently leads its immediate peer cohort in composite quantitative strength at 68/100 (C+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CLB
ACTIVE
Core Laboratories Inc. | C+ | 68/100 | 16.1x | 20.7% | 12.6% | -0.86% | $477.2M | Benchmark Subject |
| NGS Natural Gas Services Group Inc. | D- | 38/100 | 21.3x | — | 10.7% | +0.15% | $424.1M | /ngs-vs-clb → |
| RNGR Ranger Energy Services Inc. (Class A) | D+ | 57/100 | 29.4x | — | 4.2% | -0.65% | $361.3M | /rngr-vs-clb → |
| NOA North American Construction Group Ltd. (no par) | C- | 59/100 | — | — | — | -0.95% | $347.5M | /noa-vs-clb → |
| ACDC ProFrac Holding Corp. (Class A) | E | 32/100 | — | — | -11.4% | -2.81% | $883.3M | /acdc-vs-clb → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Core Laboratories Inc. (CLB) reported GAAP revenue of $526.5M (+0.5% vs. FY2024 revenue of $523.8M , and +3.3% cumulative change since FY2023) , GAAP net income of $29.7M, operating cash flow of $37.0M, and free cash flow of $25.8M (-42.0% YoY). On the balance sheet, CLB closed FY2025 with $584.0M in total assets against $110.3M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $526.5M | $29.7M | $37.0M | $25.8M | $584.0M | $110.3M |
| FY2024 (FY) | 2024-12-31 | $523.8M | $31.4M | $56.4M | $44.5M | $585.1M | $126.1M |
| FY2023 (FY) | 2023-12-31 | $509.8M | $36.7M | $24.8M | $24.8M | — | — |
As of 2026-11-01, Core Laboratories Inc. (NYSE: CLB) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $10.40 (-0.86% 1D, market cap $477.2M). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 17/20, and SEC Balance-Sheet Forensics 16/20. Across 211 tracked Energy issuers, CLB ranks #52 in composite RQD confidence.
Within the Energy sector (Oilfield Services/Equipment), CLB carries a Roarable C+ (68/100 RQD), trailing P/E of 16.1x, gross margin of 20.7%, and ROIC of 12.6%. By comparison, NGS (Natural Gas Services Group Inc.) holds a D- grade (38/100 RQD, P/E 21.3x, ROIC 10.7%, cap $424.1M) and RNGR (Ranger Energy Services Inc. (Class A)) posts a D+ grade (57/100 RQD, P/E 29.4x, ROIC 4.2%, cap $361.3M). Among the 5-stock peer group, CLB leads on earnings multiple (16.1x) while CLB leads on capital efficiency (12.6% ROIC).
Per CLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001958086), Core Laboratories Inc. generated $526.5M in revenue (+0.5% YoY), $29.7M in net income, and $25.8M in free cash flow against $584.0M in total assets and $110.3M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
CLB last traded at $10.40 (-0.86% on volume of 1,036,406 shares), positioning the stock -5.37% below its 50-day simple moving average ($10.99) and -25.02% below its 200-day simple moving average ($13.87). Across its 52-week range of $9.13 to $20.36, CLB sits at the 11.3% percentile with a 14-day RSI of 54.9 (NEUTRAL RANGE) and an implied next-earnings move of ±9.1% ($9.45 to $11.35).
Why CLB Stock slipped -0.86% Today — RQD Quant Desk Flash. Solid 21% profit margin (13% return on capital), mixed timing at 16x P/E—hold if owned, no rush to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Paper Trading Arena account.